LUNG CANCER IN YOUNG PATIENTS: CLINICO-EPIDEMIOLOGICAL AND THERAPEUTIC PROFILE
Session type: Poster / e-Poster / Silent Theatre session
Theme: Diagnosis and therapy
Lung cancer is the most common cancer in the world; and it is today the leading cancer related death, in young patients (less or equal to 45 years), lung cancer is uncommon and has clinical characteristics different from that in older patients.
The aim of our study was to analyse the epidemiologic, clinical and therapeutics of young patients with lung cancer (under 45) treated in our radiotherapy oncology department of Blida between 2010-2013
Over a period of 3 years, 31 patients were enrolled (74.2% male and 25.8 % female), median age was 39 years (range 17–45), 64.5% of patients were cigarette smokers for a median of 22 pack years (range 2–54). All patients were symptomatic at presentation; the most common symptom was cough (58%). The most common histopathology was adenocarcinoma (35.5%), followed by squamous cell carcinoma (25.5%) and small cell carcinoma (9.7%). stage IIIB and 58 % stage IV, the ECOG performance status of 1 or 2 at 74.2% and 16.1% respectively. At the time of diagnosis 9.7% had stage I/II, 32.2% stage III and 58.1% stage IV disease. The median follow up 8.7 months
Young cancer patients were predominantly male with a higher incidence of adenocarcinoma and advanced disease